110 results
8-K
EX-1.1
TPST
Tempest Therapeutics Inc
20 Jun 24
Tempest Unveils New Survival Data for Amezalpat (TPST-1120) in Randomized First-Line HCC Study Demonstrating a Six-Month Improvement over Control Arm
8:13am
by any of them and, if due and payable, any related or similar assessment, fine or penalty levied against any of them except as may be being contested
424B3
hksf wfba
27 May 22
Prospectus supplement
9:01am
8-K
EX-10.1
4geuno f9s37ni88yb
2 May 22
Tempest Announces Private Placement Financing of $15 Million
8:02am
PRE 14A
saxiwhcy0a 5r
22 Apr 22
Preliminary proxy
4:01pm